Dalbavancin was effective and safe after one year of treatment in a complicated osteoarticular infection caused by methicillin-resistant Staphylococcus aureus

Rev Esp Quimioter. 2021 Aug;34(4):396-399. doi: 10.37201/req/026.2021. Epub 2021 May 6.

Authors

M Matesanz, A Poza, A Iñurrieta, E Fernández-Diaz, M Arroyo, I Domínguez, F J Candel¹

Affiliation

¹ Francisco Javier Candel, Clinical Microbiology and Infectious Diseases IdISSC and IML Health institutes Hospital Clínico San Carlos. Madrid. Spain. franciscojavier.candel@salud.madrid.org.

No abstract available

Keywords: Dalbavancin; methicillin-resistant Staphylocoocus aureus; osteomyelitis; osteosynthesis material; suppressive antibiotic treatment.

Publication types

Letter

MeSH terms

Anti-Bacterial Agents / therapeutic use
Humans
Methicillin-Resistant Staphylococcus aureus*
Staphylococcal Infections* / drug therapy
Teicoplanin / analogs & derivatives
Teicoplanin / therapeutic use

Substances

Anti-Bacterial Agents
Teicoplanin
dalbavancin